Frontlight ResearchEarly access
Trial site
Toledo Clinic Cancer Center
- 5running trials
- 10closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer4 trials
- Childhood cancers3 trials
- Lung cancer3 trials
- Melanoma3 trials
- Colorectal cancer2 trials
- Follicular lymphoma2 trials
- Head and neck cancer2 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- Brain metastases1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- and 8 more
- Phase
- Phase 38 trials
- Phase 24 trials
- Phase 1/21 trial
- Status
- Completed7 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Terminated2 trials
- Withdrawn1 trial
- Lead sponsor
- Astellas Pharma Global Development, Inc.2 trials
- BeOne Medicines1 trial
- Celgene1 trial
- Fore Biotherapeutics1 trial
- Gilead Sciences1 trial
- and 9 more
Running trials
Recruiting
Active, not recruiting
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Bladder cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Recruiting
Recruiting
Completed
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Completed
Completed
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Terminated
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026